With the continuous advancement of pharmaceutical research, SGLT-2 inhibitors (SGLT-2i) have demonstrated cardiorenal protective effects, significantly improving adverse renal and cardiovascular outcomes in diabetic patients and reducing the risk of rehospitalization for heart failure and kidney disease.In current clinical practice, the commonly used SGLT-2i agents are recommended for use in combination with specific medications.In addition […]